Author:
Al-Salami Hani,Butt Grant,Tucker Ian,Fawcett Paul J,Golo-Corbin-Kon Svetlana,Mikov Ivan,Mikov Momir
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference41 articles.
1. Yaris F., Yaris E., Kadioglu M., Ulku C, Kesim M., Kalyoncu N.I. (2004): Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. Reprod. Toxicol., 18, 619–621.
2. Rendell M. (2004): The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs, 64, 1339–1358.
3. Faure P., Rossini E., Wiernsperger N., Richard M.J., Favier A., Halimi S. (1999): An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats. Diabetes, 48, 353–357.
4. Nöda Y., Mori A., Packer L. (1997): Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals: an ESR study. Res. Commun. Mol. Pathol. Pharmacol., 96, 115–124.
5. Florkowski CM., Richardson M.R., Le Guen C, Jennings P.E., O’Donnell M.J., Jones A.F., et al. (1988): Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus. Diabetes Res., 9, 87–90.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献